Whether there is a role for mucosal immune activation in SLE remains a matter of debate, although enhanced soluble CD14 likely related to LPS-dependent activation in gut-associated lymphoid tissues has been identified in the blood of SLE patients [32], consistent with persistent, enhanced activation of mucosal immunity. Here, CD14 is linked to systemic lupus erythematosus.